Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

“Devil Is In The Details” On Prop 65 Reform Benefits – AHPA

This article was originally published in The Tan Sheet

Executive Summary

California Governor Jerry Brown proposes to tweak Proposition 65 to reduce the number of frivolous lawsuits against small businesses. More than 10% of Prop 65 litigation targets since 2008 have been supplement firms, says the American Herbal Products Association.

You may also be interested in...



Proposed Prop 65 Changes Lighten Supplements’ Label Warning Burden

The state’s latest Prop 65 update draft makes dietary supplements follow new warning guidelines for food, rather than warnings used for consumer products. The designation makes compliance less confusing and could allow greater access to the regulation’s “natural occurring” labeling exemption.

Proposed Prop 65 Changes Lighten Supplements’ Label Warning Burden

The state’s latest Prop 65 update draft makes dietary supplements follow new warning guidelines for food, rather than warnings used for consumer products. The designation makes compliance less confusing and could allow greater access to the regulation’s “natural occurring” labeling exemption.

Regulatory News In Brief

NAD finds Nitraflex “strength” claim weak; FDA nixes BPA coating in infant formula packaging; Herbs of Light in the dark on GMPs, claims; AHPA floats softer Prop 65 warnings; and U.K. aims to end unlicensed herbal sales.

Related Content

Topics

Related Companies

Latest Headlines
See All
UsernamePublicRestriction

Register

PS106390

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel